Navigation Links
ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
Date:9/3/2009

FREMONT, Calif., Sept. 3 /PRNewswire/ -- ValGenesis, Inc. today announced the worldwide availability of the vDoc360 connector for EMC Documentum v.6.5 to increase enterprise productivity specifically for regulated Pharmaceuticals, Biotech and Medical Devices companies. The vDoc360 seamlessly integrates ValGenesis with the EMC Documentum v.6.5 Server. This integration offers Documentum customers an end-to-end secured, 100% paperless validation lifecycle management solution and central storage of validation documents provided by these two complementary technologies.

This offering will seamlessly provide global access, retrieval and storage of corporate validation data and documents generated by ValGenesis within EMC Documentum v.6.5 Server. This helps to leverage real-time reporting and the robust search functionality of Documentum Server for validation data and documents.

With the vDoc360 connector for EMC Documentum, customers can extend Documentum's access control and audit capabilities to corporate validation data and documents. Furthermore, document management staff can apply federated retention policies to unify management practices across all documents and record types throughout their organizations, ensuring consistent compliance to regulatory requirements.

"Many Life Sciences companies use Documentum for document management and want the flexibility to leverage this investment. ValGenesis continues to offer state-of-the-art ValGenesis software and now allows customers to use Documentum as the central repository for validation data and documents throughout the enterprise with this integration. ValGenesis also interfaces with many other systems, including automated test engines, to leverage the power of these test engines for validation requirements. The interface with Documentum facilitates the storage of the test data and documents generated by test engines in Documentum through configurable workflow provided by ValGenesis. ValGenesis offers Documentum users strengthened return on investment and additional usability, functionality and productivity," said Siva Samy, Ph.D., ValGenesis Chief Product Strategist.

About ValGenesis

ValGenesis offers an innovative software platform that serves as the foundation for compliance-based validation life cycle management in regulated companies by enabling a 100% paperless validation process. ValGenesis is the first Enterprise application to automate the validation lifecycle and to provide 360-degree visibility to the corporate validation process. ValGenesis is designed to fully conform to FDA 21 CFR Part 11 compliance requirements. Through an industry peer review committee, the Parenteral Drug Association (PDA) awarded ValGenesis the prestigious New Innovative Technology award.

    For more information, contact:

    Mike Beaudro, 510-445-0505, mike.beaudro@valgenesis.com
    Website:http://www.valgenesis.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE ValGenesis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
2. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
3. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
4. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
5. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
6. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
7. Buehler Motor, Inc., Significantly Expands Customer and Partner Support in North America
8. Providence-Based NABsys, Inc., Announces $4 Million Equity Financing
9. CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
10. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
11. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research and ... has announced the addition ... - Material, Application - Forecast to 2025" report to ... The report provides a detailed analysis on current ... Market forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is ... fully 21 CFR Part 11-compliant email client designed to provide product vigilance departments ...
Breaking Biology Technology:
(Date:1/19/2017)... Jan. 19, 2017 Sensory Inc ... and security for consumer electronics, and i ... systems and cybersecurity solutions, today announced a global ... financial institutions worldwide to bolster security of data ... secure user authentication platforms they offer, innerCore now ...
(Date:1/18/2017)... 2017 MedNet Solutions , an ... entire spectrum of clinical research, is proud to ... for the organization in terms of corporate growth, ... products and services. The company,s exceptional achievements can ... iMedNet ™ – ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
Breaking Biology News(10 mins):